Revier Therapeutics Launches with €6M Cardiometabolic Funding
HEIDELBERG, Germany — August 25, 2026 Revier Therapeutics has officially launched operations following the closing of a €6 million...
Drug Discovery
Advertisement
AlzeCure Receives $10M Upfront Payment From Lilly
Stockholm, Sweden, August 18, 2026 AlzeCure Pharma AB has received the full $10 million upfront payment from Eli Lilly...
Lupin Wins FDA Approval for Pitolisant Tablets
Mumbai, India and Naples, Italy, August 17, 2026 Lupin Limited, a global pharmaceutical company, announced that it has received...
OmniAb and Lilly Advance Global Ion Channel Discovery
Emeryville, California, August 17, 2026 OmniAb, Inc. has announced a new global collaboration and license agreement with Eli Lilly...
Kirin Advances AI-Native Research With GenerativeX
Tokyo, Japan, August 5, 2026 Kirin Holdings Co., Ltd. and GenerativeX Inc. have launched a new research model that...
Advertisements
Lantern Pharma Advances AI-Driven Drug Discovery Strategy
DALLAS, Aug. 14, 2026 Lantern Pharma Inc. is strengthening its position at the intersection of artificial intelligence and precision...
Evaxion AI Platform Drives Next-Gen Vaccine Development
COPENHAGEN, Denmark, August 14, 2026 Evaxion A/S (NASDAQ: EVAX) is preparing to provide a business update and second-quarter 2026...
Lupus Foundation Awards Grants to Advance Targeted Research
New York and Massachusetts, USA, August 14, 2026 The Lupus Foundation of America has announced the recipients of its...
SK bioscience Advances RSV Antibody Clinical Development
Seongnam, South Korea, August 14, 2026 SK bioscience has submitted a Clinical Trial Application (CTA) to the South African...
Genedata Advances AI Biomarker Discovery in Alzheimer’s Research
Basel, Switzerland, August 13, 2026 Genedata, a Danaher company providing enterprise software for biopharmaceutical research and development, has launched...
Advertisement
